Dual testing algorithm of bed-ceia and axsym avidity index assays performs best in identifying recent hiv infection in a sample of rwandan sex workers

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Braunstein, Sarah L ^a   Nash, Denis ^a   Kim, Andrea A ^b   Ford, Ken ^c   Mwambarangwe, Lambert ^c   Ingabire, Chantal M ^c   Vyankandondera, Joseph ^c,d   van de Wijgert, Janneke H H M ^c,e  

^a Mailman School of Public Health Columbia University ^*  (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Projet Ubuzima   (Rwanda)

^d Belgian Development Agency   (Rwanda)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ADULT; ALGORITHM; ARTICLE; ASSAY; AXSYM AVIDITY INDEX ASSAY; BED CAPTURE ENZYME IMMUNOASSAY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; PROSPECTIVE STUDY; PROSTITUTION; RWANDA; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; LABORATORY DIAGNOSIS; METHODOLOGY; SERODIAGNOSIS;

ADULT; AIDS SERODIAGNOSIS; ALGORITHMS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE REACTIONS; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; PROSTITUTION; RWANDA;

EID: 79954548575     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018402     Document Type: Article

References (36)

1. McDougal JS, Pilcher CD, Parekh BS, Gershy-Damet G, Branson BM, et al. (2005) Surveillance for HIV-1 incidence using tests for recent infection in resource-constrained countries. AIDS 19 (Suppl 2): S25-30.
2. Parekh BS, McDougal JS, (2001) New approaches to detecting recent HIV-1 infection. AIDS Review 3: 183-193.
3. Rutherford GW, Schwarcz SK, McFarland W, (2000) Surveillance for incident HIV infection: new technology and new opportunities. J Acquir Immune Defic Syndr 25 (Suppl 2): S115-119.
4. Janssen RS, Satten GA, Stramer SL, Rawal BD, O'Brien TR, et al. (1998) New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. Jama 280: 42-48.
5. Parekh BS, Kennedy MS, Dobbs T, Pau CP, Byers R, et al. (2002) Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retroviruses 18: 295-307.
6. Suligoi B, Massi M, Galli C, Sciandra M, Di Sora F, et al. (2003) Identifying recent HIV infections using the avidity index and an automated enzyme immunoassay. J Acquir Immune Defic Syndr 32: 424-428.
7. Sakarovitch C, Rouet F, Murphy G, Minga AK, Alioum A, et al. (2007) Do tests devised to detect recent HIV-1 infection provide reliable estimates of incidence in Africa? J Acquir Immune Defic Syndr 45: 115-122.
8. McDougal JS, Parekh BS, Peterson ML, Branson BM, Dobbs T, et al. (2006) Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay. AIDS Res Hum Retroviruses 22: 945-952.
9. Hargrove JW, Humphrey JH, Mutasa K, Parekh BS, McDougal JS, et al. (2008) Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay. AIDS 22: 511-518.
10. Hayashida T, Gatanaga H, Tanuma J, Oka S, (2008) Effects of Low HIV Type 1 Load and Antiretroviral Treatment on IgG-Capture BED-Enzyme Immunoassay. AIDS Res Hum Retroviruses 24: 495-498.
11. Barnighausen T, McWalter TA, Rosner Z, Newell ML, Welte A, (2010) HIV incidence estimation using the BED capture enzyme immunoassay: systematic review and sensitivity analysis. Epidemiology 21: 685-697.
12. Brookmeyer R, (2009) Should biomarker estimates of HIV incidence be adjusted? AIDS 23: 485-491.
13. Hargrove J, (2009) BED estimates of HIV incidence must be adjusted. AIDS 23: 2061-2062.
14. Welte A, McWalter TA, Barnighausen T, (2009) Reply to 'Should biomarker estimates of HIV incidence be adjusted?'. AIDS 23: 2062-2063.
15. McDougal JS, (2009) BED estimates of HIV incidence must be adjusted. AIDS 23: 2064-2065.
16. Brookmeyer R, (2009) Response to correspondence on 'Should biomarker estimates of HIV incidence be adjusted?'. AIDS 23: 2066-2068.
17. Constantine NT, Sill AM, Jack N, Kreisel K, Edwards J, et al. (2003) Improved classification of recent HIV-1 infection by employing a two-stage sensitive/less-sensitive test strategy. J Acquir Immune Defic Syndr 32: 94-103.
18. Barnighausen T, Wallrauch C, Welte A, McWalter TA, Mbizana N, et al. (2008) HIV incidence in rural South Africa: comparison of estimates from longitudinal surveillance and cross-sectional cBED assay testing. PLoS ONE 3: e3640.
19. (2005) Calypte HIV-1 BED incidence EIA (IgG-Capture HIV-EIA): enzyme immunoassay for population estimates of HIV-1 incidence. Portland, Oregon Calypte Biomedical Corporation.
20. Suligoi B, Galli C, Massi M, Di Sora F, Sciandra M, et al. (2002) Precision and accuracy of a procedure for detecting recent human immunodeficiency virus infections by calculating the antibody avidity index by an automated immunoassay-based method. J Clin Microbiol 40: 4015-4020.
21. CDC (2006) Interim recommendations for the use of the BED capture enzyme immunoassay for incidence estimation and surveillance. Atlanta, GA US Centers for Disease Control and Prevention, Surveillance and Survey and the Laboratory working groups to the Office of the Global AIDS Coordinator.
22. Parekh BS, Hanson DL, Hargrove J, Branson B, Green T, et al. (2010) Determination of Mean Recency Period for Estimation of HIV Type 1 Incidence with the BED-Capture EIA in Persons Infected with Diverse Subtypes. AIDS Res Hum Retroviruses Epub ahead of print.
23. McWalter TA, Welte A, (2009) Relating recent infection prevalence to incidence with a sub-population of assay non-progressors. J Math Biol 60: 687-710.
24. Chawla A, Murphy G, Donnelly C, Booth CL, Johnson M, et al. (2007) Human immunodeficiency virus (HIV) antibody avidity testing to identify recent infection in newly diagnosed HIV type 1 (HIV-1)-seropositive persons infected with diverse HIV-1 subtypes. J Clin Microbiol 45: 415-420.
25. Karita E, Price M, Hunter E, Chomba E, Allen S, et al. (2007) Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa. AIDS 21: 403-408.
26. (2009) Proceedings of the Meeting on the Development of Assays to Estimate HIV Incidence. Chapel Hill, North Carolina Family Health International, Gates Foundation, WHO, HPTN, CHAVI.
27. Wei X, Liu X, Dobbs T, Kuehl D, Nkengasong JN, et al. (2010) Development of two avidity-based assays to detect recent HIV type 1 seroconversion using a multisubtype gp41 recombinant protein. AIDS Res Hum Retroviruses 26: 61-71.
28. UNAIDS (2008) Epidemiological Fact Sheet- Rwanda. Geneva UNAIDS.
29. Marinda ET, Hargrove J, Preiser W, Slabbert H, van Zyl G, et al. (2010) Significantly diminished long-term specificity of the BED Capture Enzyme Immunoassay among patients with HIV-1 with very low CD4 counts and those on antiretroviral therapy. JAIDS 53: 496-500.
30. Dieltjens T, Loots N, Vereecken K, Grupping K, Heyndrickx L, et al. (2009) HIV type 1 subtype A envelope genetic evolution in a slow progressing individual with consistent broadly neutralizing antibodies. AIDS Res Hum Retroviruses 25: 1165-1169.
31. Yang OO, Daar ES, Jamieson BD, Balamurugan A, Smith DM, et al. (2005) Human immunodeficiency virus type 1 clade B superinfection: evidence for differential immune containment of distinct clade B strains. J Virol 79: 860-868.
32. Streeck H, Li B, Poon AF, Schneidewind A, Gladden AD, et al. (2008) Immune-driven recombination and loss of control after HIV superinfection. J Exp Med 205: 1789-1796.
33. Blackwelder WC, (2004) Current issues in clinical equivalence trials. J Dent Res 83 (Spec No C): C113-115.
34. Schacker T, Collier AC, Hughes J, Shea T, Corey L, (1996) Clinical and epidemiologic features of primary HIV infection. Ann Intern Med 125: 257-264.
35. Martro E, Suligoi B, Gonzalez V, Bossi V, Esteve A, et al. (2005) Comparison of the avidity index method and the serologic testing algorithm for recent human immunodeficiency virus (HIV) seroconversion, two methods using a single serum sample for identification of recent HIV infections. J Clin Microbiol 43: 6197-6199.
36. Murphy G, Charlett A, Fisher DM, McElborough D, Parry JV, (2004) Measuring antibody avidity improves the utility of STARHS in identifying recent HIV infection. Bangkok, Thailand International AIDS Conference.